Logo

People in the News: Daniel Meyer

Mar 29, 2013
Premium

GenoSpace has hired Daniel Meyer to serve as its chief financial officer.

Prior to joining the company, Meyer held positions at Arboretum Ventures and also at Point Judith Capital, where he focused on investments in life science tools, medical devices, as well as healthcare information technology and services. He also served as a member of the healthcare investment banking team at Credit Suisse First Boston.

Meyer holds a BA in mathematics and economics from Middlebury College and an MBA from the Tuck School of Business at Dartmouth.

Filed under

Informatics
GenoSpace
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.